Larapam

Tramadol Hydrochloride, the active ingredient in Larapam, is an opioid analgesic presented as an oral tablet for oral use. It is indicated for the management of moderate to severe pain in adult patients. GNH USA supplies Larapam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Larapam (Tramadol Hydrochloride) is used within the opioid analgesic pathway to relieve pain of various origins.

- Moderate to severe acute pain: provides effective analgesia for short‑term postoperative or injury‑related pain. - Chronic musculoskeletal pain: helps control persistent pain associated with conditions such as osteoarthritis. - Cancer‑related pain: used as part of a multimodal regimen to manage breakthrough pain in oncology patients.

Adverse reactions may occur with Tramadol Hydrochloride and should be monitored.

Common Side Effects: - Nausea - Dizziness - Constipation - Headache - Somnolence - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Seizures - Serotonin syndrome - Severe allergic reaction (anaphylaxis) - Dependence or addiction - Cardiac arrhythmia

When prescribing or dispensing Larapam, consider the following safety measures.

- Assess renal function: adjust use in patients with significant impairment. - Monitor for signs of dependence: limit duration and dosage as clinically appropriate. - Avoid concomitant MAO inhibitors: risk of hypertensive crisis and serotonin toxicity. - Caution in elderly patients: increased risk of falls and sedation. - Store at ambient temperature: keep in the original pack, protect from moisture.

Tramadol Hydrochloride can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, triptans): risk of serotonin syndrome. - Central nervous system depressants (benzodiazepines, barbiturates): additive sedation and respiratory depression. - Alcohol: enhances respiratory depression. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase tramadol plasma levels.

Moderate Interactions (Monitor Closely): - Carbamazepine: may reduce analgesic efficacy. - Rifampin: may lower plasma concentration. - Other antidepressants (e.g., duloxetine): monitor for serotonin excess.